In fact, we found relatively low variability of methylation measurements within individual tumor compared with the variability among different patient tumors, which further supports the potential of DAB2IP CpG1 methylation analysis for routine prognostic evaluation. This evidence concerns the gene DAB2IP and neoplasm.